Ala-Opas M - Search Results

1

Treatment of metastatic renal cancer with capsid-modified oncolytic adenoviruses.

Guse K, Ranki T, Ala-Opas M, Bono P, Särkioja M, Rajecki M, Kanerva A, Hakkarainen T, Hemminki A. Guse K, et al. Mol Cancer Ther. 2007 Oct;6(10):2728-36. doi: 10.1158/1535-7163.MCT-07-0176. Mol Cancer Ther. 2007. PMID: 17938266

2

Treatment of prostate cancer with Ad5/3Delta24hCG allows non-invasive detection of the magnitude and persistence of virus replication in vivo.

Rajecki M, Kanerva A, Stenman UH, Tenhunen M, Kangasniemi L, Särkioja M, Ala-Opas MY, Alfthan H, Sankila A, Rintala E, Desmond RA, Hakkarainen T, Hemminki A. Rajecki M, et al. Mol Cancer Ther. 2007 Feb;6(2):742-51. doi: 10.1158/1535-7163.MCT-06-0403. Mol Cancer Ther. 2007. PMID: 17308070

3

Multimodal Primary Treatment of Metastatic Prostate Cancer with Androgen Deprivation and Radiation.

Joensuu T, Joensuu G, Kairemo K, Kiljunen T, Riener M, Aaltonen A, Ala-Opas M, Kangasmäki A, Alanko T, Taipale L, Hervonen P, Bützow A, Virgolini I, Hemminki A. Joensuu T, et al. Among authors: ala opas m. Anticancer Res. 2016 Dec;36(12):6439-6447. doi: 10.21873/anticanres.11242. Anticancer Res. 2016. PMID: 27919966

4

HSV-tk gene therapy for human renal cell carcinoma in nude mice.

Pulkkanen KJ, Parkkinen JJ, Laukkanen JM, Kettunen MI, Tyynela K, Kauppinen RA, Ala-Opas MY, Yla-Herttuala S. Pulkkanen KJ, et al. Cancer Gene Ther. 2001 Jul;8(7):529-36. doi: 10.1038/sj.cgt.7700342. Cancer Gene Ther. 2001. PMID: 11498775

5

Characterization of a new animal model for human renal cell carcinoma.

Pulkkanen KJ, Parkkinen JJ, Kettunen MI, Kauppinen RA, Lappalainen M, Ala-Opas MY, Yla-Herttuala S. Pulkkanen KJ, et al. In Vivo. 2000 May-Jun;14(3):393-400. In Vivo. 2000. PMID: 10904872

6

Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.

Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Syrjänen K, Kosma VM. Aaltomaa S, et al. Br J Cancer. 1999 Aug;80(12):2001-7. doi: 10.1038/sj.bjc.6690634. Br J Cancer. 1999. PMID: 10471053 Free PMC article.

7

Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial.

Määttänen L, Hakama M, Tammela TL, Ruutu M, Ala-Opas M, Juusela H, Martikainen P, Stenman UH, Auvinen A. Määttänen L, et al. Br J Cancer. 2007 Jan 15;96(1):56-60. doi: 10.1038/sj.bjc.6603522. Br J Cancer. 2007. PMID: 17213825 Free PMC article. Clinical Trial.

8

Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer.

Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Kosma VM. Aaltomaa S, et al. Br J Cancer. 1999 May;80(3-4):477-82. doi: 10.1038/sj.bjc.6690381. Br J Cancer. 1999. PMID: 10408856 Free PMC article.

9

Concentrations of cadmium and lead in renal cell cancer.

Ala-Opas M, Tahvonen R. Ala-Opas M, et al. J Trace Elem Med Biol. 1995 Oct;9(3):176-80. doi: 10.1016/S0946-672X(11)80044-1. J Trace Elem Med Biol. 1995. PMID: 8605608

10

Orchiectomy versus oestrogen in the treatment of advanced prostatic cancer.

Haapiainen R, Rannikko S, Ruutu M, Ala-Opas M, Hansson E, Juusela H, Permi J, Saarialho M, Viitanen J, Alfthan O. Haapiainen R, et al. Br J Urol. 1991 Feb;67(2):184-7. doi: 10.1111/j.1464-410x.1991.tb15106.x. Br J Urol. 1991. PMID: 2004233

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters